3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
52
Brain Neoplasms
50
Carcinoma, Non-Small-Cell Lung
48
Neoplasm Metastasis
29
Lung Neoplasms
29
Breast Neoplasms
23
Pancreatic Neoplasms
16
Melanoma
15
Carcinoma, Renal Cell
14
Carcinoma, Hepatocellular
13
Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Urinary Bladder Neoplasms
7
Small Cell Lung Carcinoma
7
Colorectal Neoplasms
7
Kidney Neoplasms
5
Liver Neoplasms
4
Glioblastoma
4
Uveal Melanoma
3
Triple Negative Breast Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Prostate Cancer Metastatic
3
NSCLC
3
Meningioma
3
Hematologic Neoplasms
3
Head and Neck Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Transitional Cell
3
Adenocarcinoma
3
Interventions
Specimen Handling
4
lutetium Lu 177 dotatate
3
gallium Ga 68 dotatate
3
Magnetic Resonance Spectroscopy
3
olaparib
2
cabozantinib
2
belzutifan
2
Temozolomide
2
Nivolumab
2
Fluorodeoxyglucose F18
2
Biopsy
2
talazoparib
1
spartalizumab
1
pembrolizumab
1
lanreotide
1
guadecitabine
1
fludarabine phosphate
1
copper dotatate CU-64
1
atezolizumab
1
ONC206
1
Lutetium-177
1
Lutetium
1
Ipilimumab
1
Interleukin-13
1
Genetic Testing
1
Everolimus
1
Cyclophosphamide
1
Contrast Media
1
CTLA-4 Antigen
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Paraganglioma
×
Radiosurgery
×
1 year
×
Clear all
No trials found.